Form 4: Celadon Partners SPV 24 Converts Preferred Stock to Common Stock in Senti Biosciences

Celadon Partners SPV 24, a 10% owner of Senti Biosciences, converted its Series A Convertible Preferred Stock into 9,777,000 shares of Common Stock on March 10, 2025.

Summary

• Celadon Partners SPV 24, identified as a 10% owner of Senti Biosciences, Inc. (SNTI), filed a Form 4.
• The form reports a transaction that occurred on March 10, 2025, where Series A Convertible Preferred Stock was converted into Common Stock.
• Celadon Partners SPV 24 converted 9,777 shares of Series A Convertible Preferred Stock into 9,777,000 shares of Common Stock.
• The conversion was initiated by Senti Biosciences, Inc., exercising its right to automatically convert the preferred stock.
• Following the transaction, Celadon Partners SPV 24 directly owns 9,777,000 shares of Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a stock conversion, and does not inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and significant shareholders, providing transparency to the market.

Stakeholder Impact

• The conversion of preferred stock to common stock may dilute existing shareholders' ownership.

Key Dates